The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / MACRA: More Points, Smarter Future

MACRA: More Points, Smarter Future

December 14, 2016 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF

As the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) is implemented in January with new models for quality-based reimbursement payments, rheumatologists must seize control of how they will be paid now—and in the future. This message was stressed by speakers during Holy MACRA! How to Survive and Thrive in the Era of MACRA, MIPS, and APMs, an informational session held on Nov. 13 at the 2016 ACR/ARHP Annual Meeting in Washington, D.C.

You Might Also Like
  • New Research Points to Possible Future Treatment Option for Alopecia Areata
  • The ACR Advocates for More MIPS Points for RISE Use
  • Brave New MACRA World
Explore This Issue
January 2017
Also By This Author
  • The ACR Extends Its Global Outreach with a New Task Force

A Step in the Right Direction
MACRA repackages some existing, incentive-based quality payment programs, such as Meaningful Use, said William F. Harvey, MD, MSc, FACR, clinical director of the Arthritis Treatment Center at Tufts University Medical Center in Boston and a member of the ACR Board of Directors.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“While not ideal, this is certainly a step in the right direction,” said Dr. Harvey. The ACR provides education to members about MACRA reporting options, and the Rheumatology Informatics System for Effectiveness (RISE) [Registry], a free, qualified clinical data registry, allows users to immediately earn points for

William F. Harvey, MD, MSc, FACR, clinical director of the Arthritis Treatment Center at Tufts University Medical Center in Boston and a member of the ACR Board of Directors.

improved payment scores, he said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

MIPS Now, APMs Later
The Centers for Medicare and Medicaid Services (CMS) offers physicians the choice of two quality reporting pathways: participation in 1) the Merit-Based Incentive Payment Systems (MIPS) or 2) an Advanced Alternative Payment Method (APM). Most rheumatology practices will likely choose the fee-for-service MIPS track now, but CMS will continue to steer providers toward APMs in the future, said Dr. Harvey.

“Although the payment adjustments in the MIPS pathway start in 2019, the performance period for which you will collect and submit data that determine your 2019 payment adjustment starts on Jan. 1, 2017. So you need to be prepared. It’s urgent that you start thinking about this now, whether you’re an employed physician or not. This will affect you,” he said.

MACRA is budget neutral. Reimbursement money will be divided among participants on the basis of their scoring percentile, and a threshold score will divide providers who receive negative payment adjustments and those who receive positive adjustments, he said.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

MIPS: Report & Score
MIPS gives providers a score of 0 to 100 points based on their reported activities in Quality, Resource Use, Clinical Practice Improvement Activities, and Advancing Care Information, which replaces Meaningful Use. The positive payment threshold for the 2017 performance period is only three points out of 100, Dr. Harvey said. He emphasized that in response to requests from the ACR and others for more flexibility early in the program, rheumatologists can submit any single data item to avoid a negative adjustment for the first year. Providers who score 70 or more points will qualify for a pool of high-performance threshold money.

Pages: 1 2 3 4 | Single Page

Filed Under: Billing/Coding, Meeting Reports, Practice Management, Professional Topics Tagged With: 2016 ACR/ARHP Annual Meeting, Advanced Alternative Payment Method, APM, MACRA, Medicare Access and CHIP Reauthorization Act of 2015, Merit-Based Incentive Payment Systems, MIPS, RISE registryIssue: January 2017

You Might Also Like:
  • New Research Points to Possible Future Treatment Option for Alopecia Areata
  • The ACR Advocates for More MIPS Points for RISE Use
  • Brave New MACRA World
  • Rheumatology Can Use MACRA to Drive Healthcare Improvements

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.